GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Safeguard Scientifics Inc (OTCPK:SFES) » Definitions » Research & Development

Safeguard Scientifics (Safeguard Scientifics) Research & Development : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 1971. Start your Free Trial

What is Safeguard Scientifics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Safeguard Scientifics's Research & Development for the three months ended in Dec. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00 Mil.


Safeguard Scientifics Research & Development Historical Data

The historical data trend for Safeguard Scientifics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Safeguard Scientifics Research & Development Chart

Safeguard Scientifics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Safeguard Scientifics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Safeguard Scientifics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Safeguard Scientifics  (OTCPK:SFES) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Safeguard Scientifics Research & Development Related Terms

Thank you for viewing the detailed overview of Safeguard Scientifics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Safeguard Scientifics (Safeguard Scientifics) Business Description

Traded in Other Exchanges
Address
150 N. Radnor Chester Road, Suite F-200, Radnor, PA, USA, 19087
Safeguard Scientifics Inc is engaged in the development of early- and growth-stage businesses by providing capital and relevant expertise to fuel the growth of an attractive portfolio of technology-enabled healthcare, digital media, and other companies. Safeguard generally promotes the growth and development of these companies through Board representation and minority equity ownership. In addition to supporting the companies, Safeguard's strategy focuses on pursuing monetization opportunities in order to return value to shareholders.
Executives
Satterfield Thomas A Jr 10 percent owner 2609 CALDWELL MILL LN, BIRMINGHAM AL 35243
Beth Michelson director C/O CARTESIAN GROWTH CORPORATION II, 505 FIFTH AVENUE, 15TH FLOOR, NEW YORK NY 10017
Ross D Demont director 51 PICKWICK ROAD, NEWTON MA 02465
Manko Joseph M. Jr. director 1717 ARCH STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Bob Rosenthal director 20 NEWBURY ST, BOSTON MA 02116
Mark Herndon officer: SVP & Chief Financial Officer C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Eric Salzman officer: Chief Restructuring Officer C/O 8X8 INC., 675 CREEKSIDE WAY, CAMPCALL CA 95008
Ira M Lubert director C/O PENN. REAL ESTATE INVESTMENT TRUST, 200 S. BROAD ST., THE BELLEVUE, PHILADEPHIA PA 19102
John Joseph Roberts director 1007 CANTERBURY LANE, VILLANOVA PA 19085
Brian J Sisko officer: Senior V.P. & General Counsel 435 DEVON PARK DRIVE, BUILDING 800, WAYNE PA 19087
Russell D Glass director 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
David A Kille officer: Senior VP & CFO C/O SAFEGUARD SCIENTIFICS, INC., 170 N. RADNOR-CHESTER ROAD, SUITE 200, RADNOR PA 19087
Maureen F Morrison director C/O ASBURY AUTOMOTIVE GROUP, 2905 PREMIERE PKWY, STE 300, DULUTH GA 30097
Stephen T Zarrilli officer: Acting Sr VP & Acting CFO FIBERLINK COMMUNICATIONS CORP., 794 PENLLYN PIKE, BLUE BELL PA 19422
Andrew E Lietz director P O BOX 738, RYE NH 03870

Safeguard Scientifics (Safeguard Scientifics) Headlines